Financial Toxicity in Patients With Resected Localized Primary Sarcoma of the Extremities
Journal of Surgical Oncology · 10.11.2026
DOI: 10.1002/jso.70450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 10.11.2026. Verfasst von Shalin S Patel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Rolaine and Morrie Abramson Foundation, Employees and Suppliers of Womack Machine Supply Company.
Abstract (Originalsprache)
Background and Objectives Financial toxicity (FT) describes the financial burden of cancer treatment and survivorship. This topic has never been studied before in patients with localized sarcoma of the extremities.
Methods
Patients who underwent resection for localized extremity sarcoma between 2016 and 2024 were surveyed using the Comprehensive Score for Financial Toxicity (COST) questionnaire and an additional composite survey identifying risk factors and coping mechanisms for FT. Logistic regression models identified risk factors associated with FT.
Results
Two hundred and thirty‐four patients were contacted and 74 (31.6%) responded. Twenty‐eight patients (37.8%) experienced FT. Patients who experienced FT were younger ( p = 0.011), had lower household income ( p = 0.033), and had lower credit scores ( p < 0.001). Univariable analysis demonstrated that Medicare coverage (OR = 0.17, p = 0.03) and stable work hours (OR = 0.08, p = 0.004) were protective against FT. Upon multivariable analysis, credit score below 740 (OR = 26.00, p < 0.001) and being unmarried (OR = 6.48, p = 0.018) were risk factors for FT. Coping mechanisms, such as decreased spending on necessities and leisure, using savings or borrowing money, and skipping clinic visits were more likely to be reported by patients experiencing FT (all p < 0.05).
Conclusions
Patients undergoing resection for primary bone and soft tissue sarcoma of the extremities experienced high rates of FT with identifiable risk factors and coping mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Shalin S Patel, Travis W Drake, Patrick P Lin, Bryan S Moon, Valerae O Lewis
Förderung
- Rolaine and Morrie Abramson Foundation
- Employees and Suppliers of Womack Machine Supply Company
Zitieren
APA
Patel, S. S., Drake, T. W., Christie, J. L., Kemp, A. K., Lin, P. P., Satcher, R. L., Moon, B. S., Bird, J. E., & Lewis, V. O. (2026). Financial Toxicity in Patients With Resected Localized Primary Sarcoma of the Extremities. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70450
Vancouver
Patel SS, Drake TW, Christie JL, Kemp AK, Lin PP, Satcher RL, et al. Financial Toxicity in Patients With Resected Localized Primary Sarcoma of the Extremities. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70450
BibTeX
@article{Patel2026,
author = {Patel, Shalin S and Drake, Travis W and Christie, Jordan L and Kemp, Alysia K and Lin, Patrick P and Satcher, Robert L and Moon, Bryan S and Bird, Justin E and Lewis, Valerae O},
title = {Financial Toxicity in Patients With Resected Localized Primary Sarcoma of the Extremities},
journal = {Journal of Surgical Oncology},
year = {2026},
doi = {10.1002/jso.70450}
}
EUVIMED